Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
123.50    1.50 (1.24%)
Bid:
121.00
Ask:
123.50
Spread: 2.50 (2.066%)
Market Cap: £196.76m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Director Shareholding

30 Aug 2019 16:27

RNS Number : 7762K
Redcentric PLC
30 August 2019
Β 

Β 

30 August 2019

Β 

Redcentric plc

("Redcentric" or the "Company")

Β 

Director Shareholding

Β 

Β 

Redcentric plc (AIM: RCN) announces that it has received notification that Jon Kempster, Non-Executive Director, purchased 10,249 Ordinary Shares in the Company on 28 August 2019. Mr Kempster's total interest in the Company is now 10,249 Ordinary Shares, representing 0.01% of the total voting rights of the Company.

Β 

Β 

Β 

Enquiries:

Β 

Redcentric plc

Via Tulchan Communications

Peter Brotherton, Chief Executive Officer

Harn Jagpal, Company Secretary

Numis Securities - NOMAD & Joint Broker

+44 (0) 20 7260 1000

Simon Willis / Oliver Hardy

finnCap Ltd - Joint Broker

+44 (0) 20 7220 0500

Stuart Andrews / Rhys Williams

Tulchan Communications

+44 (0) 207 353 4200

James Macey White / Matt Low

Β 

Β 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with themΒ 

Β 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Jon Kempster (Non-Executive Director)

Β 

2.

Reason for the Notification

a)

Position/status

See 1(a) above

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Redcentric plc

b)

LEI

213800FGYMMNE9OKFD14

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 0.1p

Identification code

RCN GB00B7TW1V39

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Β 

Price(s)

Volume(s)

77.4p

10,249

Β 

Β 

d)

Aggregated information:

Β·; Aggregated volume

Β·; Price

See 4 (c) above

e)

Date of the transaction

28 August 2019

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHEBLFXKVFLBBE
Date   Source Headline
27th May 202512:00 pmRNSExercise of Options
27th May 20257:00 amRNSDirectorate Change
14th May 20257:00 amRNSExercise of Options
7th May 20257:00 amRNSTrading Update & CEO Appointment
25th Apr 20257:00 amRNSExercise of Options
3rd Apr 20257:00 amRNSExecutive Director Change
2nd Apr 20257:00 amRNSExercise of Options
21st Mar 20253:00 pmRNSExercise of Options
19th Feb 202512:15 pmRNSHolding(s) in Company
17th Feb 20257:00 amRNSExercise of Options
12th Feb 202511:00 amRNSExercise of Options
6th Feb 20257:00 amRNSHolding(s) in Company
5th Feb 202510:00 amRNSExercise of Options
30th Jan 20257:00 amRNSHolding(s) in Company
29th Jan 20257:00 amRNSExercise of Options
27th Jan 20257:00 amRNSBoard Change
20th Jan 20257:00 amRNSDirectorate Change - Group CEO Appointment
6th Jan 20254:00 pmRNSExercise of Options
13th Dec 20245:00 pmRNSExercise of Options
28th Nov 20247:00 amRNSExercise of Options
20th Nov 20247:00 amRNSHalf Year Results
4th Nov 202411:45 amRNSHolding(s) in Company
4th Nov 202411:30 amRNSHolding(s) in Company
1st Nov 20247:00 amRNSBoard Changes
25th Oct 20247:00 amRNSDirector/PDMR Shareholding
11th Oct 20247:00 amRNSExercise of Options
9th Oct 202410:15 amRNSExercise of Options
8th Oct 20247:00 amRNSSave As You Earn Share Option Scheme
4th Oct 20243:00 pmRNSExercise of Options
2nd Oct 20245:30 pmRNSExercise of Options
2nd Oct 20247:00 amRNSGrant of Options and PDMR Shareholding
1st Oct 20247:00 amRNSExercise of Options
27th Sep 20242:07 pmRNSResult of AGM
2nd Sep 20242:41 pmRNSPublication of Annual Report and Notice of AGM
23rd Aug 20242:36 pmRNSDirector/PDMR Shareholding
22nd Aug 20247:00 amRNSExercise of Options
15th Aug 20247:00 amRNSPreliminary results announcement FY24
8th Aug 20247:00 amRNSNotice of Results
7th Jun 202410:21 amRNSForm 8.5 (EPT/NON-RI)
6th Jun 20244:56 pmPRNStatement regarding Redcentric plc ("Redcentric")
6th Jun 202412:00 pmPRNForm 8.3 - Redcentric Plc
6th Jun 202410:25 amRNSForm 8.5 (EPT/NON-RI)
5th Jun 20242:29 pmRNSForm 8.3 - Redcentric plc
5th Jun 20249:57 amPRNForm 8.3 - Redcentric Plc
5th Jun 20247:00 amRNSForm 8.3 - Redcentric PLC
4th Jun 202412:02 pmPRNForm 8.3 - Redcentric Plc
3rd Jun 20245:56 pmRNSForm 8.3 - Redcentric PLC
3rd Jun 20241:34 pmEQSForm 8.3 - Apex Fundrock Limited : Re Redcentric plc
3rd Jun 202411:39 amPRNForm 8.3 - Redcentric Plc
3rd Jun 20249:20 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.